Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Connexus Therapeutics is a private, venture-backed biotechnology startup.
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Genesis Medtech is a medical device company.
Khartis is a drug discovery company developing oral therapies for immune-mediated and chronic diseases, with a focus on treatments and care.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.
Our purpose is to make every pregnancy around the world safer.
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.
Designing innovative technologies focused on accelerating global access to biotherapeutics.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.
Lilly Asia Ventures has invested in 105 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lilly Asia Ventures's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Life Science. The firm invests across 16 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post-IPO Equity round. Lilly Asia Ventures's total known invested capital is $9.2B.
Lilly Asia Ventures's average investment size is $122.6M across its portfolio of 105 companies.
Recent Lilly Asia Ventures portfolio additions include Connexus Therapeutics, Cornerstone Robotics, Tempest Therapeutics, Genesis Medtech, Khartis Therapeutics. These companies were founded in 2020 or later.